Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease. Retrieved May 24, 2026, from https://4ort.xyz/entity/cost-effectiveness-and-value-based-pricing-of-aducanumab-for-patients-with-early-alzheimer-disease
MLA“Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/cost-effectiveness-and-value-based-pricing-of-aducanumab-for-patients-with-early-alzheimer-disease.
BibTeX@misc{4ortxyz_cost-effectiveness-and-value-based-pricing-of-aducanumab-for-patients-with-early-alzheimer-disease_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease}}, year = {2026}, url = {https://4ort.xyz/entity/cost-effectiveness-and-value-based-pricing-of-aducanumab-for-patients-with-early-alzheimer-disease}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease — https://4ort.xyz/entity/cost-effectiveness-and-value-based-pricing-of-aducanumab-for-patients-with-early-alzheimer-disease (retrieved 2026-05-24)
